NCT00315653
- Conditions
- Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
- Locations
-
- Fujirebio Diagnostics, Inc Malvern, Pennsylvania, United States
Clinical trial condition
Bladder Cancer
Explore clinical trials studying Bladder Cancer. Study availability and eligibility vary by location and protocol.
771 public trials
174 recruiting studies
Bladder Cancer trial results
NCT00490880
- Conditions
- Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Warsaw, Poland
NCT00011518
- Conditions
- Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
- Locations
-
- Allan Smith Research Office Berkeley, California, United States
Active, Not Recruiting
Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers
NCT05891171
- Conditions
- Adenocarcinoma, Adnexal Diseases, Advanced Cancer, +64 more
- Locations
-
- Research Site Phoenix, Arizona, United States
- Research Site Jacksonville, Florida, United States
- Research Site Lake City, Florida, United States
- Research Site Hinsdale, Illinois, United States
Active, Not Recruiting
Microfluidic Urinary Exosome-Based Diagnostic Model for Bladder Cancer
NCT07735858
- Conditions
- Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
- Locations
-
- Cancer Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
Active, Not Recruiting
A Study of Several Radiation Doses for Patients With Progression on Immunotherapy/Checkpoint Inhibitors
NCT03693014
- Conditions
- Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +25 more
- Locations
-
- Hartford Healthcare Hartford, Connecticut, United States
- Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
Active, Not Recruiting
Atezolizumab Combined With BDB001 AnD Immunogenic Radiotherapy in Patients With Advanced Solid Tumors
NCT03915678
- Conditions
- Bladder Cancer, Breast Diseases, Breast Neoplasms, +45 more
- Locations
-
- Institut Bergonié Bordeaux, France
- Chu Brest Brest, France
- Centre François Baclesse Caen, France
- Centre Georges François Leclerc Dijon, France
Active, Not Recruiting
Risk-stratification Based Bladder-sparing Modalities for Muscle-invasive Bladder Cancer
NCT05531123
- Conditions
- Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, China
NCT03504163
- Conditions
- Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (All protocol activities) Montvale, New Jersey, United States
- Memorial Sloan Kettering Commack (All protocol activities) Commack, New York, United States
Active, Not Recruiting
Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women
NCT06904365
- Conditions
- Anal Cancer, Anus Diseases, Anus Neoplasms, +56 more
- Locations
-
- Washington University School of Medicine St Louis, Missouri, United States